Хайлтын үр дүнгүүд - Amy O. Johnson‐Levonas
- 8-н 1 - 8 үр дүнгүүдийг харуулж байна
-
1
Lipid-altering efficacy of ezetimibe/simvastatin 10/20 mg compared with rosuvastatin 10 mg in high-risk hypercholesterolaemic patients inadequately controlled with prior statin mon... -н Michel Farnier, Maurizio Averna, Luc Missault, H Vaverková, Margus Viigimaa, Rachid Massaad, K. Vandormael, Amy O. Johnson‐Levonas, Philippe Brudi
Хэвлэсэн 2009Artigo -
2
Changes in lipoprotein subfraction concentration and composition in healthy individuals treated with the CETP inhibitor anacetrapib -н Ronald M. Krauss, Kathleen Wojnooski, Joseph Orr, J. Casey Geaney, Cathy Anne Pinto, Yang Liu, John A. Wagner, Julie Mabalot Luk, Amy O. Johnson‐Levonas, Matt S. Anderson, Hayes M. Dansky
Хэвлэсэн 2011Artigo -
3
A phase I trial of the human double minute 2 inhibitor (MK-8242) in patients with refractory/recurrent acute myelogenous leukemia (AML) -н Farhad Ravandi, Ivana Gojo, Mrinal M. Patnaik, Mark D. Minden, Hagop M. Kantarjian, Amy O. Johnson‐Levonas, Craig Fancourt, Raymond W. Lam, Mary Jones, Clayton D. Knox, Shelonitda Rose, Payal Patel, Raoul Tibes
Хэвлэсэн 2016Artigo -
4
Phase I Trial of the Human Double Minute 2 Inhibitor MK-8242 in Patients With Advanced Solid Tumors -н Andrew J. Wagner, Udai Banerji, Amit Mahipal, Neeta Somaiah, Heather A. Hirsch, Craig Fancourt, Amy O. Johnson‐Levonas, Raymond W. Lam, Amy Meister, Giuseppe Lo Russo, Clayton D. Knox, Shelonitda Rose, David S. Hong
Хэвлэсэн 2017Artigo -
5
A Multiregional, Randomized Evaluation of the Lipid-Modifying Efficacy and Tolerability of Anacetrapib Added to Ongoing Statin Therapy in Patients With Hypercholesterolemia or Low... -н Christie M. Ballantyne, Sukrut Shah, Aditi Sapre, Tanya B. Ashraf, Sandra C. Tobias, Tayfun Şahı̇n, Ping Ye, Yugang Dong, Wayne Huey-Heng Sheu, Duk‐Hyun Kang, Paulo Roberto Ferreira ROSSI, Yulia Moiseeva, Ignacio Rodríguez Briones, Amy O. Johnson‐Levonas, Yale Mitchel
Хэвлэсэн 2017Artigo -
6
CETP (Cholesteryl Ester Transfer Protein) Inhibition With Anacetrapib Decreases Production of Lipoprotein(a) in Mildly Hypercholesterolemic Subjects -н Tiffany Thomas, Haihong Zhou, Wahida Karmally, Rajasekhar Ramakrishnan, Stephen Holleran, Yang Liu, Patricia Jumes, John A. Wagner, Brian K. Hubbard, Stephen F. Previs, Thomas P. Roddy, Amy O. Johnson‐Levonas, David E. Gutstein, Santica M. Marcovina, Daniel J. Rader, Henry N. Ginsberg, John S. Millar, Gissette Reyes‐Soffer
Хэвлэсэн 2017Artigo -
7
Effects of sotatercept on haemodynamics and right heart function: analysis of the STELLAR trial -н Rogério Souza, David B. Badesch, Hossein Ardeschir Ghofrani, J. Simon R. Gibbs, Mardi Gomberg‐Maitland, Vallerie V. McLaughlin, Ioana R. Preston, Aaron B. Waxman, Ekkehard Grünig, Grzegorz Kopeć, Gisela Meyer, Karen M. Olsson, Stephan Rosenkranz, Jianxin Lin, Amy O. Johnson‐Levonas, Janethe de Oliveira Pena, Marc Humbert, Marius M. Hoeper
Хэвлэсэн 2023Artigo -
8
Anacetrapib lowers LDL by increasing ApoB clearance in mildly hypercholesterolemic subjects -н John S. Millar, Gissette Reyes‐Soffer, Patricia Jumes, Richard L. Dunbar, Emil M. deGoma, Amanda Baer, Wahida Karmally, Daniel S. Donovan, Hashmi Rafeek, Laura Pollan, Junichiro Tohyama, Amy O. Johnson‐Levonas, John A. Wagner, Stephen Holleran, Joseph C. Obunike, Yang Liu, Rajasekhar Ramakrishnan, Michael E. Lassman, David E. Gutstein, Henry N. Ginsberg, Daniel J. Rader
Хэвлэсэн 2015Artigo
Хайх хэрэгслүүд:
Холбогдох сэдвүүд
Medicine
Internal medicine
Cholesterol
Pharmacology
Apolipoprotein B
Adverse effect
Cholesterylester transfer protein
Gastroenterology
Lipoprotein
Statin
Tolerability
Alternative medicine
Atorvastatin
Biochemistry
Chemistry
Endocrinology
Pathology
Placebo
Astrobiology
Biology
Blood pressure
Cardiology
Central venous pressure
Chemotherapy
Cholesteryl ester
Clinical trial
Cmax
Composition (language)
Ezetimibe
Heart rate